Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Apr;14(4):483-491.
doi: 10.1016/j.jalz.2017.12.006. Epub 2018 Feb 9.

The Cost of Alzheimer's Disease in China and Re-Estimation of Costs Worldwide

Affiliations
Observational Study

The Cost of Alzheimer's Disease in China and Re-Estimation of Costs Worldwide

Jianping Jia et al. Alzheimers Dement. .

Abstract

Introduction: The socioeconomic costs of Alzheimer's disease (AD) in China and its impact on global economic burden remain uncertain.

Methods: We collected data from 3098 patients with AD in 81 representative centers across China and estimated AD costs for individual patient and total patients in China in 2015. Based on this data, we re-estimated the worldwide costs of AD.

Results: The annual socioeconomic cost per patient was US $19,144.36, and total costs were US $167.74 billion in 2015. The annual total costs are predicted to reach US $507.49 billion in 2030 and US $1.89 trillion in 2050. Based on our results, the global estimates of costs for dementia were US $957.56 billion in 2015, and will be US $2.54 trillion in 2030, and US $9.12 trillion in 2050, much more than the predictions by the World Alzheimer Report 2015.

Discussion: China bears a heavy burden of AD costs, which greatly change the estimates of AD cost worldwide.

Keywords: Alzheimer's; Cost of illness; Dementia; Observational study.

Similar articles

See all similar articles

Cited by 29 articles

See all "Cited by" articles

Publication types

Feedback